| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |